nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—PHKG1—brain—bipolar disorder	0.00123	0.00281	CbGeAlD
Bosutinib—EPHB2—brain—bipolar disorder	0.00123	0.00281	CbGeAlD
Bosutinib—CASK—brain—bipolar disorder	0.00123	0.00281	CbGeAlD
Bosutinib—MAP4K4—thyroid gland—bipolar disorder	0.00122	0.00279	CbGeAlD
Bosutinib—EIF2AK1—brain—bipolar disorder	0.00121	0.00278	CbGeAlD
Bosutinib—NUAK2—thyroid gland—bipolar disorder	0.00121	0.00277	CbGeAlD
Bosutinib—BCR—thyroid gland—bipolar disorder	0.00121	0.00277	CbGeAlD
Bosutinib—MAP3K12—thyroid gland—bipolar disorder	0.0012	0.00275	CbGeAlD
Bosutinib—SRMS—brain—bipolar disorder	0.0012	0.00275	CbGeAlD
Bosutinib—FER—nervous system—bipolar disorder	0.00119	0.00272	CbGeAlD
Bosutinib—ALK—nervous system—bipolar disorder	0.00119	0.00272	CbGeAlD
Bosutinib—TYRO3—nervous system—bipolar disorder	0.00119	0.00272	CbGeAlD
Bosutinib—EPHA5—nervous system—bipolar disorder	0.00119	0.00272	CbGeAlD
Bosutinib—STK4—cerebellum—bipolar disorder	0.00119	0.00271	CbGeAlD
Bosutinib—LYN—nervous system—bipolar disorder	0.00118	0.00271	CbGeAlD
Bosutinib—STK35—thyroid gland—bipolar disorder	0.00118	0.0027	CbGeAlD
Bosutinib—FES—brain—bipolar disorder	0.00118	0.00269	CbGeAlD
Bosutinib—VRK2—brain—bipolar disorder	0.00118	0.00269	CbGeAlD
Bosutinib—EPHA8—brain—bipolar disorder	0.00118	0.00269	CbGeAlD
Bosutinib—CSK—thyroid gland—bipolar disorder	0.00117	0.00268	CbGeAlD
Bosutinib—CAMK1D—cerebellum—bipolar disorder	0.00117	0.00268	CbGeAlD
Bosutinib—MAP3K19—nervous system—bipolar disorder	0.00117	0.00267	CbGeAlD
Bosutinib—YES1—adrenal cortex—bipolar disorder	0.00117	0.00267	CbGeAlD
Bosutinib—CSNK1A1—thyroid gland—bipolar disorder	0.00116	0.00266	CbGeAlD
Bosutinib—STK24—cerebellum—bipolar disorder	0.00116	0.00265	CbGeAlD
Bosutinib—CLK1—thyroid gland—bipolar disorder	0.00116	0.00265	CbGeAlD
Bosutinib—HCK—thyroid gland—bipolar disorder	0.00116	0.00265	CbGeAlD
Bosutinib—TNIK—brain—bipolar disorder	0.00115	0.00264	CbGeAlD
Bosutinib—SYK—brain—bipolar disorder	0.00115	0.00264	CbGeAlD
Bosutinib—TAOK3—adrenal cortex—bipolar disorder	0.00115	0.00263	CbGeAlD
Bosutinib—ABL2—thyroid gland—bipolar disorder	0.00115	0.00263	CbGeAlD
Bosutinib—TNK2—nervous system—bipolar disorder	0.00114	0.00262	CbGeAlD
Bosutinib—CDK2—brain—bipolar disorder	0.00114	0.00261	CbGeAlD
Bosutinib—CAMK2G—thyroid gland—bipolar disorder	0.00113	0.0026	CbGeAlD
Bosutinib—BMP2K—thyroid gland—bipolar disorder	0.00113	0.0026	CbGeAlD
Bosutinib—STK26—brain—bipolar disorder	0.00113	0.00259	CbGeAlD
Bosutinib—LRRK2—thyroid gland—bipolar disorder	0.00112	0.00257	CbGeAlD
Bosutinib—EGFR—thyroid gland—bipolar disorder	0.00112	0.00257	CbGeAlD
Bosutinib—FER—cerebellum—bipolar disorder	0.00112	0.00256	CbGeAlD
Bosutinib—EPHA5—cerebellum—bipolar disorder	0.00112	0.00256	CbGeAlD
Bosutinib—TYRO3—cerebellum—bipolar disorder	0.00112	0.00256	CbGeAlD
Bosutinib—ERBB4—nervous system—bipolar disorder	0.00111	0.00255	CbGeAlD
Bosutinib—ROCK1—nervous system—bipolar disorder	0.0011	0.00251	CbGeAlD
Bosutinib—PTK2B—thyroid gland—bipolar disorder	0.0011	0.00251	CbGeAlD
Bosutinib—CHEK2—brain—bipolar disorder	0.00109	0.0025	CbGeAlD
Bosutinib—WEE1—brain—bipolar disorder	0.00108	0.00248	CbGeAlD
Bosutinib—DMPK—brain—bipolar disorder	0.00108	0.00248	CbGeAlD
Bosutinib—CSNK1E—thyroid gland—bipolar disorder	0.00108	0.00247	CbGeAlD
Bosutinib—TNK2—cerebellum—bipolar disorder	0.00108	0.00246	CbGeAlD
Bosutinib—BMPR2—nervous system—bipolar disorder	0.00107	0.00244	CbGeAlD
Bosutinib—SIK1—thyroid gland—bipolar disorder	0.00106	0.00243	CbGeAlD
Bosutinib—IRAK4—thyroid gland—bipolar disorder	0.00106	0.00243	CbGeAlD
Bosutinib—MAP4K2—cerebellum—bipolar disorder	0.00106	0.00243	CbGeAlD
Bosutinib—STK36—nervous system—bipolar disorder	0.00106	0.00242	CbGeAlD
Bosutinib—EPHB3—nervous system—bipolar disorder	0.00106	0.00242	CbGeAlD
Bosutinib—EPHA4—thyroid gland—bipolar disorder	0.00105	0.0024	CbGeAlD
Bosutinib—ERBB4—cerebellum—bipolar disorder	0.00105	0.0024	CbGeAlD
Bosutinib—STK3—cerebellum—bipolar disorder	0.00105	0.0024	CbGeAlD
Bosutinib—MERTK—nervous system—bipolar disorder	0.00105	0.00239	CbGeAlD
Bosutinib—ERBB3—thyroid gland—bipolar disorder	0.00104	0.00238	CbGeAlD
Bosutinib—MAP2K2—thyroid gland—bipolar disorder	0.00104	0.00237	CbGeAlD
Bosutinib—ULK3—thyroid gland—bipolar disorder	0.00104	0.00237	CbGeAlD
Bosutinib—STK25—brain—bipolar disorder	0.00104	0.00237	CbGeAlD
Bosutinib—MAP2K5—adrenal cortex—bipolar disorder	0.00103	0.00236	CbGeAlD
Bosutinib—MAP3K2—thyroid gland—bipolar disorder	0.00103	0.00236	CbGeAlD
Bosutinib—EPHA3—brain—bipolar disorder	0.00103	0.00235	CbGeAlD
Bosutinib—MAP4K4—nervous system—bipolar disorder	0.00103	0.00235	CbGeAlD
Bosutinib—MAP3K7—thyroid gland—bipolar disorder	0.00102	0.00234	CbGeAlD
Bosutinib—BCR—nervous system—bipolar disorder	0.00102	0.00233	CbGeAlD
Bosutinib—MAP3K12—nervous system—bipolar disorder	0.00101	0.00232	CbGeAlD
Bosutinib—TBK1—thyroid gland—bipolar disorder	0.00101	0.00231	CbGeAlD
Bosutinib—PTK2—thyroid gland—bipolar disorder	0.00101	0.00231	CbGeAlD
Bosutinib—PLK2—brain—bipolar disorder	0.00101	0.0023	CbGeAlD
Bosutinib—CSF1R—adrenal cortex—bipolar disorder	0.00101	0.0023	CbGeAlD
Bosutinib—BMPR2—cerebellum—bipolar disorder	0.001	0.0023	CbGeAlD
Bosutinib—SIK3—brain—bipolar disorder	0.001	0.00229	CbGeAlD
Bosutinib—EPHB3—cerebellum—bipolar disorder	0.000996	0.00228	CbGeAlD
Bosutinib—STK36—cerebellum—bipolar disorder	0.000996	0.00228	CbGeAlD
Bosutinib—MAP2K1—nervous system—bipolar disorder	0.000992	0.00227	CbGeAlD
Bosutinib—STK35—nervous system—bipolar disorder	0.000992	0.00227	CbGeAlD
Bosutinib—IRAK1—thyroid gland—bipolar disorder	0.000989	0.00226	CbGeAlD
Bosutinib—CSK—nervous system—bipolar disorder	0.000985	0.00225	CbGeAlD
Bosutinib—MERTK—cerebellum—bipolar disorder	0.000984	0.00225	CbGeAlD
Bosutinib—CSNK1A1—nervous system—bipolar disorder	0.000979	0.00224	CbGeAlD
Bosutinib—HCK—nervous system—bipolar disorder	0.000972	0.00222	CbGeAlD
Bosutinib—CLK1—nervous system—bipolar disorder	0.000972	0.00222	CbGeAlD
Bosutinib—RPS6KB1—thyroid gland—bipolar disorder	0.000971	0.00222	CbGeAlD
Bosutinib—MAP4K4—cerebellum—bipolar disorder	0.000966	0.00221	CbGeAlD
Bosutinib—LCK—thyroid gland—bipolar disorder	0.000965	0.00221	CbGeAlD
Bosutinib—FGR—thyroid gland—bipolar disorder	0.000965	0.00221	CbGeAlD
Bosutinib—STK4—brain—bipolar disorder	0.000963	0.0022	CbGeAlD
Bosutinib—AXL—thyroid gland—bipolar disorder	0.000961	0.0022	CbGeAlD
Bosutinib—NUAK2—cerebellum—bipolar disorder	0.000959	0.00219	CbGeAlD
Bosutinib—BCR—cerebellum—bipolar disorder	0.000959	0.00219	CbGeAlD
Bosutinib—BMP2K—nervous system—bipolar disorder	0.000954	0.00218	CbGeAlD
Bosutinib—CAMK2G—nervous system—bipolar disorder	0.000954	0.00218	CbGeAlD
Bosutinib—MAP3K12—cerebellum—bipolar disorder	0.000952	0.00218	CbGeAlD
Bosutinib—CAMK1D—brain—bipolar disorder	0.000951	0.00218	CbGeAlD
Bosutinib—LRRK2—nervous system—bipolar disorder	0.000946	0.00216	CbGeAlD
Bosutinib—STK24—brain—bipolar disorder	0.00094	0.00215	CbGeAlD
Bosutinib—STK35—cerebellum—bipolar disorder	0.000933	0.00214	CbGeAlD
Bosutinib—MAP2K1—cerebellum—bipolar disorder	0.000933	0.00214	CbGeAlD
Bosutinib—CSK—cerebellum—bipolar disorder	0.000927	0.00212	CbGeAlD
Bosutinib—SLK—thyroid gland—bipolar disorder	0.000925	0.00212	CbGeAlD
Bosutinib—PTK2B—nervous system—bipolar disorder	0.000922	0.00211	CbGeAlD
Bosutinib—CSNK1A1—cerebellum—bipolar disorder	0.000921	0.00211	CbGeAlD
Bosutinib—EPHB4—thyroid gland—bipolar disorder	0.000918	0.0021	CbGeAlD
Bosutinib—CLK1—cerebellum—bipolar disorder	0.000915	0.00209	CbGeAlD
Bosutinib—FER—brain—bipolar disorder	0.00091	0.00208	CbGeAlD
Bosutinib—EPHA5—brain—bipolar disorder	0.00091	0.00208	CbGeAlD
Bosutinib—TYRO3—brain—bipolar disorder	0.00091	0.00208	CbGeAlD
Bosutinib—ALK—brain—bipolar disorder	0.00091	0.00208	CbGeAlD
Bosutinib—ABL2—cerebellum—bipolar disorder	0.000909	0.00208	CbGeAlD
Bosutinib—CSNK1E—nervous system—bipolar disorder	0.000907	0.00208	CbGeAlD
Bosutinib—LYN—brain—bipolar disorder	0.000905	0.00207	CbGeAlD
Bosutinib—EPHA2—thyroid gland—bipolar disorder	0.000901	0.00206	CbGeAlD
Bosutinib—FYN—thyroid gland—bipolar disorder	0.000899	0.00206	CbGeAlD
Bosutinib—CAMK2G—cerebellum—bipolar disorder	0.000898	0.00206	CbGeAlD
Bosutinib—BMP2K—cerebellum—bipolar disorder	0.000898	0.00206	CbGeAlD
Bosutinib—SIK1—nervous system—bipolar disorder	0.000893	0.00204	CbGeAlD
Bosutinib—IRAK4—nervous system—bipolar disorder	0.000893	0.00204	CbGeAlD
Bosutinib—PDGFRB—adrenal cortex—bipolar disorder	0.000893	0.00204	CbGeAlD
Bosutinib—MAP3K19—brain—bipolar disorder	0.000891	0.00204	CbGeAlD
Bosutinib—MAP4K1—brain—bipolar disorder	0.000891	0.00204	CbGeAlD
Bosutinib—LRRK2—cerebellum—bipolar disorder	0.00089	0.00204	CbGeAlD
Bosutinib—EGFR—cerebellum—bipolar disorder	0.000887	0.00203	CbGeAlD
Bosutinib—BTK—brain—bipolar disorder	0.000887	0.00203	CbGeAlD
Bosutinib—EPHA4—nervous system—bipolar disorder	0.000884	0.00202	CbGeAlD
Bosutinib—MAP4K5—thyroid gland—bipolar disorder	0.000879	0.00201	CbGeAlD
Bosutinib—MAP3K3—thyroid gland—bipolar disorder	0.000879	0.00201	CbGeAlD
Bosutinib—ERBB3—nervous system—bipolar disorder	0.000875	0.002	CbGeAlD
Bosutinib—TNK2—brain—bipolar disorder	0.000874	0.002	CbGeAlD
Bosutinib—MAP2K2—nervous system—bipolar disorder	0.000873	0.002	CbGeAlD
Bosutinib—ULK3—nervous system—bipolar disorder	0.000873	0.002	CbGeAlD
Bosutinib—PTK2B—cerebellum—bipolar disorder	0.000867	0.00198	CbGeAlD
Bosutinib—MAP3K2—nervous system—bipolar disorder	0.000867	0.00198	CbGeAlD
Bosutinib—MAP4K2—brain—bipolar disorder	0.000862	0.00197	CbGeAlD
Bosutinib—CSNK1E—cerebellum—bipolar disorder	0.000853	0.00195	CbGeAlD
Bosutinib—ERBB4—brain—bipolar disorder	0.00085	0.00195	CbGeAlD
Bosutinib—STK3—brain—bipolar disorder	0.00085	0.00195	CbGeAlD
Bosutinib—PTK2—nervous system—bipolar disorder	0.000849	0.00194	CbGeAlD
Bosutinib—TBK1—nervous system—bipolar disorder	0.000849	0.00194	CbGeAlD
Bosutinib—SIK1—cerebellum—bipolar disorder	0.00084	0.00192	CbGeAlD
Bosutinib—IRAK4—cerebellum—bipolar disorder	0.00084	0.00192	CbGeAlD
Bosutinib—ROCK1—brain—bipolar disorder	0.000839	0.00192	CbGeAlD
Bosutinib—EPHA4—cerebellum—bipolar disorder	0.000832	0.0019	CbGeAlD
Bosutinib—ERBB3—cerebellum—bipolar disorder	0.000823	0.00188	CbGeAlD
Bosutinib—ULK3—cerebellum—bipolar disorder	0.000821	0.00188	CbGeAlD
Bosutinib—MAP2K2—cerebellum—bipolar disorder	0.000821	0.00188	CbGeAlD
Bosutinib—RPS6KB1—nervous system—bipolar disorder	0.000817	0.00187	CbGeAlD
Bosutinib—MAP3K2—cerebellum—bipolar disorder	0.000816	0.00187	CbGeAlD
Bosutinib—BMPR2—brain—bipolar disorder	0.000815	0.00187	CbGeAlD
Bosutinib—YES1—thyroid gland—bipolar disorder	0.000812	0.00186	CbGeAlD
Bosutinib—FGR—nervous system—bipolar disorder	0.000812	0.00186	CbGeAlD
Bosutinib—STK36—brain—bipolar disorder	0.000809	0.00185	CbGeAlD
Bosutinib—EPHB3—brain—bipolar disorder	0.000809	0.00185	CbGeAlD
Bosutinib—AXL—nervous system—bipolar disorder	0.000808	0.00185	CbGeAlD
Bosutinib—MAP3K7—cerebellum—bipolar disorder	0.000808	0.00185	CbGeAlD
Bosutinib—STK10—thyroid gland—bipolar disorder	0.000804	0.00184	CbGeAlD
Bosutinib—TAOK3—thyroid gland—bipolar disorder	0.000801	0.00183	CbGeAlD
Bosutinib—MERTK—brain—bipolar disorder	0.000799	0.00183	CbGeAlD
Bosutinib—TBK1—cerebellum—bipolar disorder	0.000799	0.00183	CbGeAlD
Bosutinib—PTK2—cerebellum—bipolar disorder	0.000799	0.00183	CbGeAlD
Bosutinib—ABL1—adrenal cortex—bipolar disorder	0.000796	0.00182	CbGeAlD
Bosutinib—MAP4K4—brain—bipolar disorder	0.000785	0.0018	CbGeAlD
Bosutinib—IRAK1—cerebellum—bipolar disorder	0.000783	0.00179	CbGeAlD
Bosutinib—SRC—thyroid gland—bipolar disorder	0.000781	0.00179	CbGeAlD
Bosutinib—NUAK2—brain—bipolar disorder	0.000779	0.00178	CbGeAlD
Bosutinib—BCR—brain—bipolar disorder	0.000779	0.00178	CbGeAlD
Bosutinib—MAP3K12—brain—bipolar disorder	0.000774	0.00177	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—bipolar disorder	0.000768	0.00176	CbGeAlD
Bosutinib—AXL—cerebellum—bipolar disorder	0.000761	0.00174	CbGeAlD
Bosutinib—MAP2K1—brain—bipolar disorder	0.000758	0.00173	CbGeAlD
Bosutinib—STK35—brain—bipolar disorder	0.000758	0.00173	CbGeAlD
Bosutinib—EPHA2—nervous system—bipolar disorder	0.000758	0.00173	CbGeAlD
Bosutinib—FYN—nervous system—bipolar disorder	0.000757	0.00173	CbGeAlD
Bosutinib—CSK—brain—bipolar disorder	0.000753	0.00172	CbGeAlD
Bosutinib—CSNK1A1—brain—bipolar disorder	0.000748	0.00171	CbGeAlD
Bosutinib—CLK1—brain—bipolar disorder	0.000743	0.0017	CbGeAlD
Bosutinib—HCK—brain—bipolar disorder	0.000743	0.0017	CbGeAlD
Bosutinib—MAP3K3—nervous system—bipolar disorder	0.000739	0.00169	CbGeAlD
Bosutinib—MAP4K5—nervous system—bipolar disorder	0.000739	0.00169	CbGeAlD
Bosutinib—ABL2—brain—bipolar disorder	0.000739	0.00169	CbGeAlD
Bosutinib—SLK—cerebellum—bipolar disorder	0.000732	0.00168	CbGeAlD
Bosutinib—BMP2K—brain—bipolar disorder	0.00073	0.00167	CbGeAlD
Bosutinib—CAMK2G—brain—bipolar disorder	0.00073	0.00167	CbGeAlD
Bosutinib—EPHB4—cerebellum—bipolar disorder	0.000727	0.00166	CbGeAlD
Bosutinib—LRRK2—brain—bipolar disorder	0.000723	0.00165	CbGeAlD
Bosutinib—EGFR—brain—bipolar disorder	0.000721	0.00165	CbGeAlD
Bosutinib—MAP2K5—thyroid gland—bipolar disorder	0.000718	0.00164	CbGeAlD
Bosutinib—FYN—cerebellum—bipolar disorder	0.000712	0.00163	CbGeAlD
Bosutinib—PTK2B—brain—bipolar disorder	0.000705	0.00161	CbGeAlD
Bosutinib—CSF1R—thyroid gland—bipolar disorder	0.000701	0.0016	CbGeAlD
Bosutinib—MAP4K5—cerebellum—bipolar disorder	0.000696	0.00159	CbGeAlD
Bosutinib—MAP3K3—cerebellum—bipolar disorder	0.000696	0.00159	CbGeAlD
Bosutinib—CSNK1E—brain—bipolar disorder	0.000693	0.00159	CbGeAlD
Bosutinib—CYP3A4—blood plasma—bipolar disorder	0.000689	0.00158	CbGeAlD
Bosutinib—YES1—nervous system—bipolar disorder	0.000683	0.00156	CbGeAlD
Bosutinib—SIK1—brain—bipolar disorder	0.000682	0.00156	CbGeAlD
Bosutinib—IRAK4—brain—bipolar disorder	0.000682	0.00156	CbGeAlD
Bosutinib—STK10—nervous system—bipolar disorder	0.000677	0.00155	CbGeAlD
Bosutinib—EPHA4—brain—bipolar disorder	0.000676	0.00155	CbGeAlD
Bosutinib—TAOK3—nervous system—bipolar disorder	0.000674	0.00154	CbGeAlD
Bosutinib—ERBB3—brain—bipolar disorder	0.000669	0.00153	CbGeAlD
Bosutinib—MAP2K2—brain—bipolar disorder	0.000667	0.00153	CbGeAlD
Bosutinib—ULK3—brain—bipolar disorder	0.000667	0.00153	CbGeAlD
Bosutinib—MAP3K2—brain—bipolar disorder	0.000662	0.00152	CbGeAlD
Bosutinib—SRC—nervous system—bipolar disorder	0.000657	0.0015	CbGeAlD
Bosutinib—MAP3K7—brain—bipolar disorder	0.000656	0.0015	CbGeAlD
Bosutinib—PTK2—brain—bipolar disorder	0.000649	0.00148	CbGeAlD
Bosutinib—TBK1—brain—bipolar disorder	0.000649	0.00148	CbGeAlD
Bosutinib—YES1—cerebellum—bipolar disorder	0.000642	0.00147	CbGeAlD
Bosutinib—STK10—cerebellum—bipolar disorder	0.000637	0.00146	CbGeAlD
Bosutinib—IRAK1—brain—bipolar disorder	0.000636	0.00146	CbGeAlD
Bosutinib—TAOK3—cerebellum—bipolar disorder	0.000634	0.00145	CbGeAlD
Bosutinib—RPS6KB1—brain—bipolar disorder	0.000624	0.00143	CbGeAlD
Bosutinib—PDGFRB—thyroid gland—bipolar disorder	0.000622	0.00142	CbGeAlD
Bosutinib—FGR—brain—bipolar disorder	0.00062	0.00142	CbGeAlD
Bosutinib—SRC—cerebellum—bipolar disorder	0.000618	0.00141	CbGeAlD
Bosutinib—AXL—brain—bipolar disorder	0.000618	0.00141	CbGeAlD
Bosutinib—MAP2K5—nervous system—bipolar disorder	0.000604	0.00138	CbGeAlD
Bosutinib—SLK—brain—bipolar disorder	0.000595	0.00136	CbGeAlD
Bosutinib—EPHB4—brain—bipolar disorder	0.00059	0.00135	CbGeAlD
Bosutinib—CSF1R—nervous system—bipolar disorder	0.00059	0.00135	CbGeAlD
Bosutinib—EPHA2—brain—bipolar disorder	0.000579	0.00133	CbGeAlD
Bosutinib—FYN—brain—bipolar disorder	0.000578	0.00132	CbGeAlD
Bosutinib—MAP2K5—cerebellum—bipolar disorder	0.000569	0.0013	CbGeAlD
Bosutinib—MAP4K5—brain—bipolar disorder	0.000565	0.00129	CbGeAlD
Bosutinib—MAP3K3—brain—bipolar disorder	0.000565	0.00129	CbGeAlD
Bosutinib—CSF1R—cerebellum—bipolar disorder	0.000555	0.00127	CbGeAlD
Bosutinib—ABL1—thyroid gland—bipolar disorder	0.000554	0.00127	CbGeAlD
Bosutinib—PDGFRB—nervous system—bipolar disorder	0.000523	0.0012	CbGeAlD
Bosutinib—YES1—brain—bipolar disorder	0.000522	0.00119	CbGeAlD
Bosutinib—STK10—brain—bipolar disorder	0.000517	0.00118	CbGeAlD
Bosutinib—TAOK3—brain—bipolar disorder	0.000515	0.00118	CbGeAlD
Bosutinib—SRC—brain—bipolar disorder	0.000502	0.00115	CbGeAlD
Bosutinib—PDGFRB—cerebellum—bipolar disorder	0.000492	0.00113	CbGeAlD
Bosutinib—ABCB1—blood plasma—bipolar disorder	0.000487	0.00112	CbGeAlD
Bosutinib—ABL1—nervous system—bipolar disorder	0.000466	0.00107	CbGeAlD
Bosutinib—MAP2K5—brain—bipolar disorder	0.000462	0.00106	CbGeAlD
Bosutinib—CSF1R—brain—bipolar disorder	0.000451	0.00103	CbGeAlD
Bosutinib—ABL1—cerebellum—bipolar disorder	0.000439	0.001	CbGeAlD
Bosutinib—PDGFRB—brain—bipolar disorder	0.0004	0.000915	CbGeAlD
Bosutinib—ABL1—brain—bipolar disorder	0.000356	0.000815	CbGeAlD
Bosutinib—ABCB1—adrenal cortex—bipolar disorder	0.000247	0.000566	CbGeAlD
Bosutinib—CYP3A4—nervous system—bipolar disorder	0.000205	0.000469	CbGeAlD
Bosutinib—ABCB1—thyroid gland—bipolar disorder	0.000172	0.000394	CbGeAlD
Bosutinib—ABCB1—nervous system—bipolar disorder	0.000145	0.000332	CbGeAlD
Bosutinib—ABCB1—cerebellum—bipolar disorder	0.000136	0.000312	CbGeAlD
Bosutinib—ABCB1—brain—bipolar disorder	0.000111	0.000254	CbGeAlD
Bosutinib—MAP2K1—Signaling Pathways—GSK3A—bipolar disorder	1.4e-05	2.49e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—DRD4—bipolar disorder	1.39e-05	2.48e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—IL1B—bipolar disorder	1.39e-05	2.47e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HTR2A—bipolar disorder	1.39e-05	2.47e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—IL1B—bipolar disorder	1.39e-05	2.46e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ADM—bipolar disorder	1.38e-05	2.45e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NCAN—bipolar disorder	1.38e-05	2.45e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—ADCY2—bipolar disorder	1.37e-05	2.44e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—DRD4—bipolar disorder	1.37e-05	2.44e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NRG1—bipolar disorder	1.37e-05	2.44e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—S100B—bipolar disorder	1.37e-05	2.43e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TCF7L2—bipolar disorder	1.37e-05	2.43e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—DRD4—bipolar disorder	1.37e-05	2.43e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—ADCY2—bipolar disorder	1.36e-05	2.42e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—DRD2—bipolar disorder	1.36e-05	2.41e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—MTHFR—bipolar disorder	1.36e-05	2.41e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—GSK3B—bipolar disorder	1.36e-05	2.41e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—GSK3B—bipolar disorder	1.36e-05	2.41e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—TCF7L2—bipolar disorder	1.36e-05	2.41e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NRG1—bipolar disorder	1.35e-05	2.4e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SLC5A3—bipolar disorder	1.35e-05	2.4e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TSHB—bipolar disorder	1.35e-05	2.39e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PDE4B—bipolar disorder	1.35e-05	2.39e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TACR1—bipolar disorder	1.35e-05	2.39e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—POMC—bipolar disorder	1.34e-05	2.39e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—ADCY2—bipolar disorder	1.34e-05	2.38e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TCF7L2—bipolar disorder	1.34e-05	2.37e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NRG1—bipolar disorder	1.33e-05	2.36e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—DRD2—bipolar disorder	1.33e-05	2.36e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—MTHFR—bipolar disorder	1.32e-05	2.35e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—ADCY2—bipolar disorder	1.31e-05	2.33e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—HTR2A—bipolar disorder	1.31e-05	2.33e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TCF7L2—bipolar disorder	1.31e-05	2.32e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR1A—bipolar disorder	1.31e-05	2.32e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—DRD2—bipolar disorder	1.3e-05	2.31e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—ADCY2—bipolar disorder	1.29e-05	2.3e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TCF7L2—bipolar disorder	1.29e-05	2.29e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—POMC—bipolar disorder	1.29e-05	2.29e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TAC1—bipolar disorder	1.29e-05	2.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—ADCY2—bipolar disorder	1.29e-05	2.28e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NRG1—bipolar disorder	1.28e-05	2.28e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—S100B—bipolar disorder	1.28e-05	2.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TCF7L2—bipolar disorder	1.28e-05	2.27e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—NRG1—bipolar disorder	1.28e-05	2.27e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—DRD2—bipolar disorder	1.28e-05	2.27e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—MTHFR—bipolar disorder	1.28e-05	2.27e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL1B—bipolar disorder	1.27e-05	2.26e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—DRD2—bipolar disorder	1.27e-05	2.26e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—MTHFR—bipolar disorder	1.27e-05	2.26e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—GSK3B—bipolar disorder	1.27e-05	2.25e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DRD1—bipolar disorder	1.26e-05	2.24e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR2C—bipolar disorder	1.26e-05	2.24e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—POMC—bipolar disorder	1.26e-05	2.24e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR1A—bipolar disorder	1.26e-05	2.24e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—INS—bipolar disorder	1.25e-05	2.22e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—GSK3B—bipolar disorder	1.25e-05	2.22e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—POMC—bipolar disorder	1.24e-05	2.2e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TAC1—bipolar disorder	1.24e-05	2.2e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HTR2A—bipolar disorder	1.24e-05	2.2e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—INS—bipolar disorder	1.23e-05	2.19e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NTRK1—bipolar disorder	1.23e-05	2.19e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NTRK2—bipolar disorder	1.23e-05	2.18e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—NRG1—bipolar disorder	1.23e-05	2.18e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DRD3—bipolar disorder	1.22e-05	2.17e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HTR2A—bipolar disorder	1.22e-05	2.17e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—GSK3A—bipolar disorder	1.22e-05	2.16e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DRD1—bipolar disorder	1.22e-05	2.16e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR2C—bipolar disorder	1.22e-05	2.16e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NRG1—bipolar disorder	1.21e-05	2.15e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—GSK3B—bipolar disorder	1.2e-05	2.14e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—POMC—bipolar disorder	1.2e-05	2.14e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—IMPA1—bipolar disorder	1.2e-05	2.13e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NTRK1—bipolar disorder	1.2e-05	2.13e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—S100B—bipolar disorder	1.2e-05	2.13e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—POMC—bipolar disorder	1.2e-05	2.12e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—INS—bipolar disorder	1.19e-05	2.11e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DRD4—bipolar disorder	1.19e-05	2.11e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—GSK3B—bipolar disorder	1.19e-05	2.11e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NTRK2—bipolar disorder	1.18e-05	2.1e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—NRG1—bipolar disorder	1.18e-05	2.1e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DRD3—bipolar disorder	1.18e-05	2.09e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NTRK1—bipolar disorder	1.18e-05	2.09e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—GSK3A—bipolar disorder	1.17e-05	2.08e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—S100B—bipolar disorder	1.17e-05	2.07e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—GSK3B—bipolar disorder	1.16e-05	2.06e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—GSK3B—bipolar disorder	1.16e-05	2.06e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NTRK1—bipolar disorder	1.16e-05	2.06e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HTR2A—bipolar disorder	1.16e-05	2.06e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—GSK3B—bipolar disorder	1.16e-05	2.06e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NTRK1—bipolar disorder	1.15e-05	2.05e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—POMC—bipolar disorder	1.15e-05	2.05e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—POMC—bipolar disorder	1.15e-05	2.05e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—INS—bipolar disorder	1.15e-05	2.03e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—INS—bipolar disorder	1.15e-05	2.03e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—S100B—bipolar disorder	1.14e-05	2.03e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DRD4—bipolar disorder	1.14e-05	2.03e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL1B—bipolar disorder	1.13e-05	2.01e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—GSK3B—bipolar disorder	1.13e-05	2.01e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—NRG1—bipolar disorder	1.13e-05	2.01e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—GSK3B—bipolar disorder	1.13e-05	2e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—S100B—bipolar disorder	1.13e-05	2e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—S100B—bipolar disorder	1.12e-05	1.99e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—GSK3B—bipolar disorder	1.12e-05	1.99e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL1B—bipolar disorder	1.12e-05	1.99e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ADCY2—bipolar disorder	1.12e-05	1.98e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—GSK3B—bipolar disorder	1.12e-05	1.98e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR1A—bipolar disorder	1.11e-05	1.98e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TCF7L2—bipolar disorder	1.11e-05	1.98e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—POMC—bipolar disorder	1.11e-05	1.97e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—GSK3B—bipolar disorder	1.11e-05	1.97e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DRD2—bipolar disorder	1.1e-05	1.96e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—INS—bipolar disorder	1.1e-05	1.96e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—MTHFR—bipolar disorder	1.1e-05	1.96e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TAC1—bipolar disorder	1.1e-05	1.95e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—GSK3B—bipolar disorder	1.09e-05	1.94e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR2A—bipolar disorder	1.09e-05	1.94e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—INS—bipolar disorder	1.08e-05	1.92e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2C—bipolar disorder	1.08e-05	1.91e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD1—bipolar disorder	1.08e-05	1.91e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ADCY2—bipolar disorder	1.08e-05	1.91e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TCF7L2—bipolar disorder	1.07e-05	1.9e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—GSK3B—bipolar disorder	1.07e-05	1.9e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DRD2—bipolar disorder	1.06e-05	1.89e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—MTHFR—bipolar disorder	1.06e-05	1.89e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL1B—bipolar disorder	1.06e-05	1.88e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NRG1—bipolar disorder	1.06e-05	1.88e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—INS—bipolar disorder	1.05e-05	1.87e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NTRK2—bipolar disorder	1.05e-05	1.86e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—POMC—bipolar disorder	1.05e-05	1.86e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—NRG1—bipolar disorder	1.05e-05	1.86e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD3—bipolar disorder	1.04e-05	1.85e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—GSK3A—bipolar disorder	1.04e-05	1.84e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NRG1—bipolar disorder	1.03e-05	1.83e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—GSK3B—bipolar disorder	1.03e-05	1.83e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—GSK3B—bipolar disorder	1.02e-05	1.82e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.02e-05	1.81e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—INS—bipolar disorder	1.02e-05	1.8e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD4—bipolar disorder	1.01e-05	1.8e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—INS—bipolar disorder	1.01e-05	1.79e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NRG1—bipolar disorder	1.01e-05	1.79e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NTRK1—bipolar disorder	1e-05	1.78e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL1B—bipolar disorder	9.99e-06	1.77e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—GSK3B—bipolar disorder	9.96e-06	1.77e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NRG1—bipolar disorder	9.93e-06	1.76e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	9.89e-06	1.76e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NRG1—bipolar disorder	9.88e-06	1.75e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—POMC—bipolar disorder	9.88e-06	1.75e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—INS—bipolar disorder	9.82e-06	1.75e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—GSK3B—bipolar disorder	9.82e-06	1.74e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CLOCK—bipolar disorder	9.77e-06	1.74e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—POMC—bipolar disorder	9.74e-06	1.73e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—S100B—bipolar disorder	9.72e-06	1.73e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—INS—bipolar disorder	9.69e-06	1.72e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NTRK1—bipolar disorder	9.64e-06	1.71e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—GSK3B—bipolar disorder	9.63e-06	1.71e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—TSHB—bipolar disorder	9.52e-06	1.69e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—TPH2—bipolar disorder	9.52e-06	1.69e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CACNB2—bipolar disorder	9.52e-06	1.69e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ADCY2—bipolar disorder	9.52e-06	1.69e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR2A—bipolar disorder	9.52e-06	1.69e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TCF7L2—bipolar disorder	9.49e-06	1.69e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD2—bipolar disorder	9.42e-06	1.67e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—MTHFR—bipolar disorder	9.41e-06	1.67e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—S100B—bipolar disorder	9.37e-06	1.66e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—DPYD—bipolar disorder	9.37e-06	1.66e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—GSK3B—bipolar disorder	9.32e-06	1.65e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR2A—bipolar disorder	9.29e-06	1.65e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—GSK3B—bipolar disorder	9.28e-06	1.65e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—POMC—bipolar disorder	9.24e-06	1.64e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—INS—bipolar disorder	9.19e-06	1.63e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR2A—bipolar disorder	9.1e-06	1.62e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR2A—bipolar disorder	8.96e-06	1.59e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR2A—bipolar disorder	8.91e-06	1.58e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—GSK3B—bipolar disorder	8.9e-06	1.58e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NR1D1—bipolar disorder	8.89e-06	1.58e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—INS—bipolar disorder	8.77e-06	1.56e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—GSK3B—bipolar disorder	8.77e-06	1.56e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL1B—bipolar disorder	8.73e-06	1.55e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CACNA1C—bipolar disorder	8.71e-06	1.55e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—POMC—bipolar disorder	8.7e-06	1.55e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—INS—bipolar disorder	8.65e-06	1.54e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NRG1—bipolar disorder	8.58e-06	1.52e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—GSK3B—bipolar disorder	8.57e-06	1.52e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NTRK1—bipolar disorder	8.53e-06	1.52e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL1B—bipolar disorder	8.52e-06	1.51e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NCAN—bipolar disorder	8.5e-06	1.51e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	8.49e-06	1.51e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—INS—bipolar disorder	8.46e-06	1.5e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL1B—bipolar disorder	8.34e-06	1.48e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	8.33e-06	1.48e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL1B—bipolar disorder	8.3e-06	1.47e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—S100B—bipolar disorder	8.29e-06	1.47e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NRG1—bipolar disorder	8.27e-06	1.47e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—GSK3B—bipolar disorder	8.22e-06	1.46e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL1B—bipolar disorder	8.21e-06	1.46e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL1B—bipolar disorder	8.17e-06	1.45e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR2A—bipolar disorder	7.74e-06	1.37e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—GSK3B—bipolar disorder	7.67e-06	1.36e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SNAP25—bipolar disorder	7.61e-06	1.35e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—POMC—bipolar disorder	7.6e-06	1.35e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—GSK3B—bipolar disorder	7.59e-06	1.35e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—INS—bipolar disorder	7.56e-06	1.34e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—INS—bipolar disorder	7.49e-06	1.33e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—GSK3B—bipolar disorder	7.48e-06	1.33e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR2A—bipolar disorder	7.46e-06	1.32e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—POMC—bipolar disorder	7.42e-06	1.32e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—INS—bipolar disorder	7.38e-06	1.31e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—GSK3B—bipolar disorder	7.32e-06	1.3e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NRG1—bipolar disorder	7.32e-06	1.3e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—POMC—bipolar disorder	7.26e-06	1.29e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—INS—bipolar disorder	7.22e-06	1.28e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—GSK3B—bipolar disorder	7.21e-06	1.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—GSK3B—bipolar disorder	7.17e-06	1.27e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—POMC—bipolar disorder	7.15e-06	1.27e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—POMC—bipolar disorder	7.11e-06	1.26e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—INS—bipolar disorder	7.11e-06	1.26e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—bipolar disorder	7.09e-06	1.26e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—INS—bipolar disorder	7.07e-06	1.26e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—bipolar disorder	6.83e-06	1.21e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ADCY2—bipolar disorder	6.74e-06	1.2e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—bipolar disorder	6.6e-06	1.17e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—GSK3B—bipolar disorder	6.23e-06	1.11e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—POMC—bipolar disorder	6.18e-06	1.1e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—INS—bipolar disorder	6.14e-06	1.09e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—bipolar disorder	6.05e-06	1.07e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CLOCK—bipolar disorder	6.02e-06	1.07e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—GSK3B—bipolar disorder	6e-06	1.07e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—POMC—bipolar disorder	5.95e-06	1.06e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—INS—bipolar disorder	5.92e-06	1.05e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TSHB—bipolar disorder	5.87e-06	1.04e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TPH2—bipolar disorder	5.87e-06	1.04e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CACNB2—bipolar disorder	5.87e-06	1.04e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DPYD—bipolar disorder	5.77e-06	1.03e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—COMT—bipolar disorder	5.77e-06	1.02e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MAOA—bipolar disorder	5.73e-06	1.02e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	5.37e-06	9.53e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—GSK3B—bipolar disorder	5.31e-06	9.44e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—bipolar disorder	5.27e-06	9.36e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—INS—bipolar disorder	5.24e-06	9.31e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	5.23e-06	9.29e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SNAP25—bipolar disorder	4.69e-06	8.33e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—bipolar disorder	4.66e-06	8.28e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADCY2—bipolar disorder	4.15e-06	7.37e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—bipolar disorder	3.73e-06	6.63e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—INS—bipolar disorder	3.71e-06	6.59e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—COMT—bipolar disorder	3.55e-06	6.31e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOA—bipolar disorder	3.53e-06	6.27e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—bipolar disorder	2.87e-06	5.1e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—bipolar disorder	2.3e-06	4.08e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—INS—bipolar disorder	2.29e-06	4.06e-06	CbGpPWpGaD
